General Information of the Compound
| Compound ID |
CP0385103
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CAS_87075-17-0
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+)-SCH-23390
(1S)-7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol
(5S)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol
AC1O7G1X
BDBM82248
CAS_73445-63-3
CHEMBL63321
GOTMKOSCLKVOGG-HNNXBMFYSA-N
GTPL956
Lopac-D-054
NCGC00015301-01
PDSP1_000616
PDSP1_001624
PDSP2_000613
PDSP2_001608
SCH 23388 (S-enantiomer)
SCH-23390
SCHEMBL11107859
Sch-23388
ZINC2017840
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H18ClNO
|
||||||||||||||||||
| Molecular Weight |
287.79
|
||||||||||||||||||
| Canonical SMILES |
CN1CCc2cc(Cl)c(O)cc2C(C1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
GOTMKOSCLKVOGG-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
87075-17-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Clinical Information about the Compound